Identification of Novel Single-Domain Antibodies against FGF7 Using Phage Display Technology
Identification of Novel Single-Domain Antibodies against FGF7 Using Phage Display Technology.
نویسندگان: بهزاد جعفری , مریم حمزه میوه رود , سیاوش دستمالچی
کلمات کلیدی: FGF7, phage display, single domain antibody, ELISA, CD spectropolarimetry
نشریه: 55974 , 2 , 23 , 2018
| نویسنده ثبت کننده مقاله |
سیاوش دستمالچی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات بیوتکنولوژی(زیست فناوری) |
| کد مقاله |
68263 |
| عنوان فارسی مقاله |
Identification of Novel Single-Domain Antibodies against FGF7 Using Phage Display Technology |
| عنوان لاتین مقاله |
Identification of Novel Single-Domain Antibodies against FGF7 Using Phage Display Technology. |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Fibroblast growth factor 7 (FGF7) is a member of the fibroblast growth factor (FGF) family of proteins. FGF7 is of stromal
origin and produces a paracrine effect on epithelial cells. In the current investigation, we aimed to identify new singledomain antibodies (sdAbs) against FGF7 using phage display technology. The vector harboring the codon-optimized DNA
sequence for FGF7 protein was transformed into Escherichia coli BL21 (DE3) pLysS, and then the protein was expressed at
the optimized condition. Enzyme-linked immunosorbent assay, circular dichroism spectropolarimetry, and in vitro scratch
assay experiments were used to confirm the proper folding and functionality of the purified FGF7 protein. The purity of the
produced FGF7 was 92%, with production yield of 3.5 mg/L of culture. Panning against the purified FGF7 was performed,
and the identified single-domain antibodies showed significant affinity. Further investigation on one of the selected sdAb
displaying phage clones showed concentration-dependent binding to FGF7. The selected sdAb can be used for developing
novel tumor-suppressing agents where inhibition of FGF7 is required. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 2472555217728520.pdf | 1398/06/12 | 196936 | دانلود |